Gene · 1645
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acetylsalicylic Acid-Primus Inter Pares in Pharmacology. | Molecules | 2022 | 36500502 | PubTator, text mining | PubMed |
| Induction of Cardiac Pathology: Endogenous versus Exogenous Nrf2 Upregulation. | Cells | 2022 | 36497112 | PubTator, text mining | PubMed |
| The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial. | PLoS One | 2022 | 36480560 | PubTator, text mining | PubMed |
| Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro. | J Prev Med Hyg | 2022 | 36479497 | PubTator, text mining | PubMed |
| Human iPSC-hepatocyte modeling of alpha-1 antitrypsin heterozygosity reveals metabolic dysregulation and cellular heterogeneity. | Cell Rep | 2022 | 36476855 | PubTator, text mining | PubMed |
| METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10. | Cancer Cell Int | 2022 | 36476503 | PubTator, text mining | PubMed |
| Identification of Small Airway Epithelium-Related Hub Genes in Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2022 | 36475041 | PubTator, text mining | PubMed |
| Targeting ferroptosis, the achilles' heel of breast cancer: A review. | Front Pharmacol | 2022 | 36467032 | PubTator, text mining | PubMed |
| Epstein-Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments. | Int J Mol Sci | 2022 | 36430864 | PubTator, text mining | PubMed |
| (-)-Epigallocatechin-3-Gallate Prevents IL-1β-Induced uPAR Expression and Invasiveness via the Suppression of NF-κB and AP-1 in Human Bladder Cancer Cells. | Int J Mol Sci | 2022 | 36430487 | PubTator, text mining | PubMed |
| Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428603 | PubTator, text mining | PubMed |
| Identification of Ferroptosis-Related Genes in Schizophrenia Based on Bioinformatic Analysis. | Genes (Basel) | 2022 | 36421842 | PubTator, text mining | PubMed |
| A pilot reverse virtual screening study suggests toxic exposures caused long-term epigenetic changes in Gulf War Illness. | Comput Struct Biotechnol J | 2022 | 36420170 | PubTator, text mining | PubMed |
| Role of Human Aldo-Keto Reductases in the Nitroreduction of 1-Nitropyrene and 1,8-Dinitropyrene. | Chem Res Toxicol | 2022 | 36399404 | PubTator, text mining | PubMed |
| Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor. | J Med Chem | 2022 | 36395526 | PubTator, text mining | PubMed |
| A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients. | Front Oncol | 2022 | 36387100 | PubTator, text mining | PubMed |
| A Review of Potential Therapeutic Strategies for COVID-19. | Viruses | 2022 | 36366444 | PubTator, text mining | PubMed |
| Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine. | Pharmaceutics | 2022 | 36365185 | PubTator, text mining | PubMed |
| Comparative Analysis of Coumarin Profiles in Different Parts of Peucedanum japonicum and Their Aldo-Keto Reductase Inhibitory Activities. | Molecules | 2022 | 36364218 | PubTator, text mining | PubMed |
| Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance. | Int J Mol Sci | 2022 | 36362304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1645/papers?page=16